ArticleNeuro-oncology advances

Combination treatment with RAF/MEK inhibitor avutometinib and FAK inhibitor defactinib in preclinical models of meningioma.

Nazanin Ijad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.